Ϫ7 M ANG II was effective in producing desensitization (remaining response was 66.8 Ϯ 2.1% of nondesensitized cells). Desensitization was a concentration-related event (EC 50 : 1.1 nM). Although partial recovery was obtained 15 min after removal of ANG II, full response could not be achieved even after 4 h (77.6 Ϯ 2.4%). Experiments with 5 ϫ 10 Ϫ7 M ionomycin indicated that intracellular Ca 2ϩ stores of desensitized cells had already recovered when desensitization was still significant. The thyrotropin-releasing hormone (TRH)-induced intracellular Ca 2ϩ peak was attenuated in the ANG II-pretreated group. ANG II pretreatment also desensitized ANG II-and TRH-induced inositol phosphate generation (72.8 Ϯ 3.5 and 69.6 Ϯ 6.1%, respectively, for inositol triphosphate) and prolactin secretion (53.4 Ϯ 2.3 and 65.1 Ϯ 7.2%), effects independent of PKC activation. We conclude that, in pituitary cells, inositol triphosphate formation, [Ca 2ϩ ] i mobilization, and prolactin release in response to ANG II undergo rapid, long-lasting, homologous and heterologous desensitization.
angiotensin type 1 receptor; thyrotropin-releasing hormone; calcium; homologous desensitization; protein kinase C ANGIOTENSIN II (ANG II) type 1 (AT 1 ) receptors belong to the family of plasma membrane receptors that couple to guanine nucleotide regulatory proteins [guanine nucleotide protein-coupled receptors (GPCR)]. Two subtypes have been described: AT 1A and AT 1B . In the rat pituitary, activation of AT 1B receptors coupled to G q/11 protein increases phospholipase C-␤ (PLC-␤) activity, resulting in increased inositol 1,4,5-triphosphate [Ins(1,4,5)P 3 ] and diacylglycerol formation. A biphasic increase in intracellular calcium concentration ([Ca 2ϩ ] i ) triggered by Ins(1,4,5)P 3 ensues. In a previous study (16) we showed that the initial transient [Ca 2ϩ ] i spike, which is primarily due to Ins(1,4,5)P 3 -mediated release of intracellular Ca 2ϩ , is followed by a sustained [Ca 2ϩ ] i elevation that results from increased Ca 2ϩ influx through voltage-sensitive calcium channels and capacitative Ca 2ϩ entry. The initial [Ca 2ϩ ] i spike is terminated as Ins(1,4,5)P 3 concentration declines, intracellular Ca 2ϩ stores become exhausted, and cytoplasmic Ca 2ϩ is sequestered by intracellular organelles or pumped out from the cells. DAG, together with the increased [Ca 2ϩ ] i , stimulates protein kinase C (PKC) activity. Activation of this pathway by ANG II in lactotrophs results in prolactin secretion (10) .
It is well recognized that, in the presence of agonists, many transmembrane GPCRs not only display rapid activation of signal transduction but also rapid desensitization of response (31) . Receptor desensitization is potentially a physiologically important process, as it provides a means of regulating continuous receptor stimulation. Rapid receptor desensitization does not necessarily involve receptor loss but rather receptor phosphorylation (36) . This acute process (seconds to minutes) may be supplemented by internalization (minutes to hours) and by downregulation (hours to days) of membrane receptors.
Both AT 1 receptor subtypes (AT 1A and AT 1B ) undergo rapid homologous desensitization in response to ANG II. This has been reported in the adrenal gland (28) , vascular smooth muscle cells (2) , rat cardiomyocytes (1), renal afferent arterioles (21), brain (14) , and Chinese hamster ovary (CHO) cells (34) . In particular, desensitization of ANG II receptors in the pituitary has not been documented. Different degrees and temporal patterns of desensitization have been reported for PLC-␤-coupled receptors, and it is believed that desensitization may be a cell-specific phenomenon, regulated by differential expression of elements involved in the process. Moreover, it is well established that signaling and desensitization of GPCRs can be influenced by the cell type in which they are expressed, as in the case of the mouse thyrotropin-releasing hormone (TRH) recep-tor (12) . This raises the possibility that ANG II desensitization may be a function of the cell type rather than of AT 1 receptor structure.
We therefore assessed whether rapid desensitization of the AT 1 receptor occurs in anterior pituitary cells by use of repetitive stimulation of intracellular Ca 2ϩ mobilization, inositol triphosphate generation, and prolactin secretion as end points. We also determined whether heterologous desensitization occurred by use of TRH as a second alternative stimulus and the participation of PKC in the desensitization process.
MATERIALS AND METHODS

Animals.
Female 60-day-old Sprague-Dawley rats were housed in an air-conditioned room with lights on at 0700 and off at 1900. They had free access to laboratory chow and tap water. Female rats were checked by vaginal cytology for regular estrous cycles during Ն10 days previous to the experiment. Rats in diestrus were used.
Cell dispersion. Unless specified, all drugs were purchased from Sigma (St. Louis, MO).
Rats were killed by decapitation at 9:00 AM, and pituitaries were removed on ice, separated from the neurointermediate lobe, and placed in chambers containing freshly prepared Krebs-Ringer bicarbonate buffer (KRBGA) without Ca 2ϩ or Mg 2ϩ . Buffer contained 14 mM glucose, 1% bovine seroalbumin, MEM amino acids 2%, MEM vitamins 1% (GIBCO, Buenos Aires, Argentina), 2 mM glutamine, and Phenol Red 0.025%. It was previously gassed for 15 min with 95% O 2 -5% CO 2 and adjusted to pH 7.35-7.40. Buffer was sterilized by filtration through a 0.45-m pore diameter membrane (Nalgene). Pituitaries were washed three times with KRBGA and then cut into 1-mm pieces. Fragments obtained were washed and incubated in the same buffer containing 0.5% trypsin for 30 min at 37°C, with 95% O 2 -5% CO 2 . They were treated for two additional minutes with 50 l DNase I (1 mg/ml, Worthington, Lakewood, NJ). Digestion was ended by addition of 1 mg/ml LBI. Fragments were dispersed in individual cells by gentle trituration through siliconized Pasteur pipettes. Resulting suspension was filtered through a nylon gauze (160 m) and centrifuged for 10 min at 120 g. Before centrifugation, an aliquot of cellular suspension was taken to quantify hypophysial cell yield by use of a Neubauer chamber. Viability of cells, determined by trypan blue exclusion, was always Ͼ90%. In a series of experiments, cells were freshly used for intracellular Ca 2ϩ measurements; alternatively, they were cultured for 4 days (as will be described).
Intracellular Ca 2ϩ measurements. Measurements were made as previously described (11) . Briefly, the tetraacetoxymethyl ester (AM) of fura 2 was used as a fluorescent indicator. The pellet of anterior pituitary cells of each experimental group was redispersed and incubated in a buffered saline solution (BSS: 140 mM NaCl, 3.9 mM KCl, 0.7 mM KH 2 PO 4 , 0.5 mM Na 2 HPO 4 ⅐ 12H 2 O, 1 mM CaCl 2 , 0.5 mM MgCl 2 , and 20 mM HEPES, pH 7.4) in the presence of 1.5 M fura 2-AM, 10 mM glucose, and 0.1% BSA. Cells were incubated for 30 min at 37°C in an atmosphere of 95% O 2 -5% CO 2 , a time during which fura 2 is trapped intracellularly by esterase cleavage. Cells were then washed twice in BSS without fura 2-AM and brought to a density of 1.7-2 ϫ 10 6 cells/ml BSS. Fluorescence was measured in a spectrofluorometer (Jasco, Tokyo, Japan) provided with the accessory CA-261 to measure Ca 2ϩ with continuous stirring, a thermostat adjusted to 37°C, and an injection chamber. Intracellular Ca 2ϩ levels were registered every second by exposure to alternating 340-and 380-nm light beams, and the intensity of light emission at 505 nm was measured. In this way light intensities and their ratio (F 340 /F 380 ) were followed. Drugs were injected (5 l) into the chamber as a 100-fold concentrated solution without interruption of recording. The preparation was calibrated, and maximal fluorescence (F max ) was determined by addition of 0.1% Triton X-100 and minimal fluorescence (F min Cell culture. Cell pellets were resuspended in DMEM, supplemented with 10% horse serum, 2.5% fetal calf serum, 1% MEM nonessential amino acids, 25,000 U/l of nystatin, and 25 ng/l gentamicin. Cells were plated in sterile tissue culture plates (Cluster 24, Corning; 500,000 cells per well) and incubated with 1 ml DMEM (GIBCO) in a metabolic incubator at 37°C with 5% CO 2 -95% O 2 .
Desensitization of ANG II-induced cellular inositol phosphate accumulation and prolactin secretion. After 4 days in culture, cells were washed twice with DMEM and F-12 Nutrient Mixture (GIBCO), supplemented with 1% BSA, 2 mM glutamine, and the same concentration of antibiotics, to remove all traces of serum. Fresh medium containing 4 Ci/ml myo- [2- 3 H(N)]inositol (specific activity: 20 Ci/mmol; New England Nuclear, Boston, MA) was added, and cells were incubated at 37°C for 24 h. At the end of the labeling period, cells were washed twice with DMEM-F-12 supplemented with 1% BSA, 2 mM glutamine, 25,000 U/l nystatin, and 25 ng/l gentamicin. Cells were pretreated with buffer or first stimulated with 1 ϫ 10 Ϫ7 ANG II for 10 min, and stimulus was removed by washing. Thereafter, cells were further incubated for 105 min in DMEM-F12. Medium was replaced, and cells were incubated with 20 mM LiCl for 15 min to allow accumulation of inositol phosphate species. A second stimulus of 1 ϫ 10 Ϫ9 or 1 ϫ 10 Ϫ7 M ANG II, 1 ϫ 10 Ϫ7 M TRH, or buffer (control) was then applied to the cells in duplicate. For analysis of prolactin secretion, samples were taken 30 min after drug administration. Samples were stored at Ϫ20°C until analyzed by RIA after appropriate dilution in 0.01 M PBS with 1% egg albumin. Cells were placed on ice, treated with 0.5 M cold perchloric acid, and scraped for inositol phosphate determination. Experiments were repeated four times. Times and concentrations were chosen according to our previous experience (4) .
Inositol phosphate accumulation. Inositol phosphates were measured as previously described (3), with minor modifications. Well contents were transferred to tubes and centrifuged for 10 min at 3,000 rpm (4°C). Pellets were kept for DNA measurement. The supernatants were neutralized (0.72 M KOH-0.6 M HKCO 3 ) and chromatographed on Dowex columns (AG-1-X8, 200-400 mesh, formate form, Bio-Rad, Buenos Aires, Argentina) to elute inositol monophosphate (InsP), diphosphate (InsP 2 ), and triphosphate (InsP 3 ). Phosphate esters were eluted by the stepwise addition of solutions containing increasing levels of formate. Specifically, they were sequentially eluted with 10 mM inositol (for free . Two-milliliter aliquots of each wash fraction were mixed with 6 ml Optiphase "Hisafe" 3 (Wallac Oy, Turku, Finland) and counted in a liquid scintillation counter.
PKC downregulation. PKC was downregulated in vitro by a 24-h pretreatment of cultured cells with 1 M phorbol 12-myristate 13-acetate (PMA). Homologous and heterologous desensitization of prolactin response by ANG II pretreatment was tested as we have described. Downregulation of PKC was confirmed by the inability of a 30-min stimulation with 1 M PMA (PMA30) to release prolactin in PMApretreated cells (PMA24), (PMA30: 274.5 Ϯ 52.0; PMA30ϩPMA24: 9.4 Ϯ 12.6 prolactin increase in ng/ml, P ϭ 0.023).
RIA. Prolactin was measured by RIA using kits provided by the National Institute of Diabetes and Digestive and Kidney Diseases. Results are expressed in terms of prolactin PRL RP 3 . Intra-and interassay coefficients of variation were 7.2 and 12.8%, respectively.
Statistical analyses. Results are expressed as means Ϯ SE. For [Ca 2ϩ ] i measurements, peak values were analyzed by one-way ANOVA for repeated measures. Individual means were then compared by Duncan's test (desensitized vs. control). Prolactin secretion and inositol phosphate generation in vitro were analyzed by two-way ANOVA for repeated measures for the effects of drug treatment and group (control or desensitized). If an F of interaction was found significant, individual means were compared by Scheffé's test; if it was not significant, groups of means were analyzed by the same test. Basal prolactin and inositol phosphates were analyzed by Student's t-test. P Ͻ 0.05 was considered significant. [Ca 2ϩ ] i . The amplitude of the [Ca 2ϩ ] i spike depended on ANG II concentration, reaching an apparent maximum at 10 nM. At higher concentrations, the [Ca 2ϩ ] i response occurred earlier and more synchronically, with a steeper upstroke (Fig. 1) . The EC 50 for peak amplitude was 2.3 nM. Incubation time required for desensitization. To determine the briefest ANG II exposure that would cause desensitization, 1 ϫ 10 Ϫ7 M ANG II was applied for varying periods of time (1, 5, 10, or 20 min) to pituitary cells in culture. Cells were washed repeatedly and subjected to a second 1 ϫ 10 Ϫ7 M ANG II pulse after 120 min. ANG II-induced [Ca 2ϩ ] i increase was already desensitized after 1 min of pretreatment (Fig. 3) . The response obtained was 66.8 Ϯ 2.1% of maximal response (P ϭ 0.044), and this percentage did not change significantly with increasing incubation periods. For subsequent experiments, a 10-min pretreatment was chosen.
RESULTS
Desensitization of ANG II-mediated increase in
Recovery of Ca 2ϩ response. In light of the susceptibility of cells to desensitization, we further assessed the ability of desensitized cells to recover. Cells were subjected to a 10-min pretreatment with 1 ϫ 10 Ϫ7 M ANG II and then washed with medium devoid of ANG II and incubated for varying periods before the second pulse of 1 ϫ 10 Ϫ7 M ANG II. The Ca 2ϩ response recovered partially after 15 min but remained at only 41.4 Ϯ 2.6% of the control response (P ϭ 0.00016 vs. control). The response to ANG II was still different from the control value 4 h after the initial ANG II stimulus (77.6 Ϯ 2.4%, P ϭ 0.00022; Fig. 4 Fig. 6 , the TRH-induced Ca 2ϩ peak was attenuated in the ANG II-pretreated group and reached only 60.3% of levels attained in the control group (P ϭ 0.001). 
ANG II-mediated homologous and heterologous desensitization of inositol phosphate generation.
To ascertain whether homologous and heterologous desensitization of PLC-␤ function occurred, we determined the effect of a 10-min pretreatment with 1 ϫ 10 Ϫ7 M ANG II on the ability of ANG II or TRH to generate inositol phosphates 2 h later. Basal levels of the three inositol phosphate species were increased in cells previously treated with ANG II. Basal levels in buffer-pretreated cells were 452.3 Ϯ 37.3, 95.4 Ϯ 8.7, and 32.63 Ϯ 2.79 counts ⅐ min Ϫ1 (cpm) ⅐ g DNA Ϫ1 Ϯ SE for InsP, InsP 2 , and InsP 3 , respectively, and in ANG II-pretreated cells, levels were 802.2 Ϯ 57.3, 171.6 Ϯ 12.8, and 52.65 Ϯ 1.67 cpm/g DNA (P ϭ 0.038 control vs. desensitized for the three inositol phosphate species). Such increment was probably related to the effect of ANG II pretreatment, which was prolonged by addition of LiCl, which prevents inositol phosphate breakdown. When we evaluated absolute increments after the second stimulus, similar patterns of response were found for the three inositol phosphate species. InsP 3 production was lower in desensitized cells (response to 1 ϫ 10 Ϫ9 and 1 ϫ 10 Ϫ7 M ANG II was 69.8 Ϯ 3.5 and 72.8 Ϯ 3.5% of control cells, P ϭ 0.045; Fig. 7, left) , and both InsP 2 and InsP production was also lower in these cells (P ϭ 0.05 and 0.046, respectively; Fig. 7, middle and  right) . Interestingly, the response of inositol phosphates to 1 ϫ 10 Ϫ7 M TRH was also desensitized by previous treatment with ANG II (response was 69.6 Ϯ 6.1% that of control response for InsP 3 , P ϭ 0.045).
ANG II-mediated homologous and heterologous desensitization of prolactin secretion. Response to the secretory activity of ANG II was also desensitized, because a pretreatment with 1 ϫ 10 Ϫ7 M ANG II for 10 min significantly reduced ANG II-induced prolactin secretion 2 h later (Fig. 8) . The response was only 64.3 Ϯ 9.9 and 53.4 Ϯ 2.3% of that achieved in the control group for the concentrations of 1 ϫ 10 Ϫ9 and 1 ϫ 10 Ϫ7 M ANG II, respectively (P ϭ 0.022). Response of prolactin secretion to 1 ϫ 10 Ϫ7 M TRH was also decreased (65.1 Ϯ 7.2% of control response, P ϭ 0.022) by a desensitizing pretreatment with ANG II. Fig. 9 ; P ϭ 0.043). In PMA-pretreated cells, ANG II-induced homologous and heterologous desensitization was still observed.
Involvement of PKC on ANG II-mediated heterologous desensitization of prolactin secretion and Ca
We also tested ANG II-induced heterologous desensitization of the Ca 2ϩ response to TRH in PMA-pretreated and untreated cells. We found that the degree of desensitization was similar in both groups (remaining response to TRH in untreated and PMA-pretreated cells was 70.0 Ϯ 8.0 and 78.1 Ϯ 5.2%, respectively, NS).
DISCUSSION
The octapeptide ANG II binds and activates receptors in the plasma membrane of target cells, thereby Ϫ7 M ANG II (Desensitized) for 10 min, washed, and incubated for 2 h in agonist-free medium. A second stimulus of ANG II or TRH was then added, and samples were taken 30 min later. Results are expressed as absolute increment over basal levels; they represent means Ϯ SE of 4 independent experiments performed in duplicate. Basal levels of PRL release in control and desensitized cells were 874 Ϯ 55 and 990 Ϯ 59 ng/ml (P ϭ 0.038). *P ϭ 0.022 vs. respective undesensitized cells. mediating a variety of important cardiovascular, homeostatic, and neuroendocrine functions. A brain-renin-ANG II, as well as a pituitary-renin-ANG II, system has been well characterized, and there are particularly high levels of ANG II in the hypothalamus. ANG II receptors are present in both the hypothalamus and the anterior pituitary of several species. Studies from numerous laboratories have shown that ANG II affects pituitary prolactin, growth hormone, adrenocorticotropin, and luteinizing hormone acting at the hypothalamus and/or the pituitary, and receptor number varies in physiologically diverse conditions (29) . We have demonstrated that ANG II activates AT 1 pituitary receptors, and that inositol phosphate generation, [Ca 2ϩ ] i increase, and prolactin stimulation ensue (10, 16) .
In many cells or tissues, exposure of ANG II receptors to ANG II often leads to a rapid loss of receptor responsiveness, or receptor desensitization. This has been described in cells from the kidney, heart, adrenal gland, and brain (1, 2, 14, 21, 28, 34) . In the present study, we describe for the first time ANG II-induced homologous and heterologous desensitization of intracellular Ca 2ϩ mobilization, InsP 3 generation, and prolactin release in dispersed anterior pituitary cells.
It has been documented that desensitization is an event associated with receptor structure as well as with the cell type in which the receptor is expressed (12) . It is therefore understandable that different temporal and functional aspects of ANG II receptor desensitization have been described.
The desensitization of the ANG II-induced Ca 2ϩ response was a concentration-related phenomenon reaching an apparent maximum at 1 ϫ 10 Ϫ7 M, and desensitization could not be overcome by using higher concentrations of ANG II (data not shown). The EC 50 that induced homologous desensitization (1.1 nM) was in the range of the dissociation constant K d for the AT 1 receptor in the pituitary (8) . It was also similar to that obtained for ANG II-induced desensitization of Ins(1,4,5)P 3 production in CHO cells (33) .
In contrast to the present results, in CHO-K1 cells expressing the AT 1 receptor (34, 35) after an initial stimulus with a subsaturating concentration (1 ϫ 10 Ϫ9 M) of ANG II, no response in [Ca 2ϩ ] i was observed to a second ANG II challenge added 2 min later. We observed that 1 ϫ 10 Ϫ9 M ANG II reduced the subsequent response to 34.2%, which was still a significant response. In human embryonal kidney, 293 cells stably expressing AT 1A receptors, cells initially stimulated with 1 ϫ 10 Ϫ7 M ANG II were refractory to a second ANG II stimulus 4 min later, as in the present work (18) . Transfected cell systems represent a useful tool to study cellular mechanisms, but they may not reliably reflect the actual mechanism present in cells endogenously expressing AT 1 receptors. Particularly when desensitization is considered, discrepant results may be related to different amounts of expressed receptors or differential cell expression of elements involved in the mechanism of desensitization.
We next evaluated the extent of desensitization in relation to the duration of the initial stimulus. When cells were stimulated by ANG II and then washed and tested for desensitization 2 h later, an initial stimulus as short as 1 min was effective in producing maximal desensitization. This time course resembles desensitization of the AT 1A receptor in rat cardiomyocytes and in CHO cells, where rapid desensitization can occur even if receptor internalization is inhibited (1, 32) . This suggests that receptor desensitization and internalization are distinct events, even though they can occur concurrently. In CHO cells expressing the AT 1B receptor, there was also a rapid (few minutes) and dosedependent homologous desensitization of receptor-mediated production of second messengers (25, 33) . Nevertheless, it has been shown that in bovine adrenal glomerulosa cells, AT 1 receptors are resistant to shortterm desensitization and that long-term pretreatments with high concentrations of ANG II are needed to desensitize AT 1 -mediated cellular responses (28) . This may reflect the influence of cell type on the AT 1 receptor sensitivity to desensitization.
When ANG II was washed, the cells recovered the ability to increase [Ca 2ϩ ] i in response to a second ANG II stimulus already at 15 min, even though maximal response could not be obtained at that time. Full recovery from the desensitized state required more than 4 h. In CHO-K1 cells, a small response could be obtained 30 min after the initial stimulus, and an incomplete resensitization was observed 60 min after washing the initial stimulus. In contrast, in bovine adrenal glomerulosa cells, desensitization of the AT 1B receptor was a reversible phenomenon, because most of the binding capacity was recovered after 60 min (28) .
The lack of full recovery of Ca 2ϩ response in desensitized pituitary cells could be related to a depleted intracellular Ca 2ϩ pool. This was verified by using ionomycin 120 min after a desensitizing treatment with ANG II. We found that Ca 2ϩ stores had fully recovered by that time, suggesting that Ca 2ϩ pool depletion might not account for ANG II-induced desensitization. In contrast, it has been described that gonadotropin-releasing hormone-induced desensitization of calcium response in the pituitary rapidly recovers (37) in parallel with a rapid replenishment of Ca 2ϩ stores (23) .
Desensitization was accompanied by a decrease of PLC-␤ function, as assessed by measurement of InsP 3 and by a decrease in prolactin release in response to a second stimulus of ANG II. Desensitization in all cases was not complete, because a response of 54 to 72% could be obtained depending on the parameter measured. A similar degree of desensitization of Ins(1,4,5)P 3 response to ANG II has been described in cultured smooth muscle cells (20) and in CHO cells stably transfected with the AT 1A receptor (9) . This suggests that the desensitized Ca 2ϩ response could be due to impaired InsP 3 production. The fact that the prolactin response was also desensitized would indicate that lactotropes are target cells of ANG II-induced desensitization. Nevertheless, response of corticotropes could also be involved, inasmuch as it has been described that AT 1B receptors are present in both lactotropes and corticotropes in the pituitary, lactotropes being the predominant cell type in the female pituitary (22) .
ANG II pretreatment also desensitized TRH-induced Ca 2ϩ mobilization, InsP 3 generation, and prolactin release. This would indicate that a common element in the signal transduction pathway of ANG II and TRH was desensitized by ANG II. In this regard, both ANG II and TRH receptors interact with the pertussis toxininsensitive Gq/G11 class of G proteins (19, 29) . It has been proposed that, within any given cell, there is a limited pool of G proteins shared by a variety of endogenous receptors. It is possible that ANG II receptor stimulation and subsequent receptor uncoupling, or receptor G protein internalization, limits the G protein pool available to couple to other endogenously expressed receptors, in this case the TRH receptor.
Current evidence suggests that the initial, most rapid phase of desensitization occurs with a time course of seconds to minutes after exposure to an agonist and involves agonist-induced phosphorylation of GPCRs, uncoupling of the receptors from G proteins, and a loss of subsequent downstream events (7, 13) . GPCRs can be phosphorylated by two different types of kinases: 1) second messenger-activated kinases, such as protein kinase A or PKC, which produce a negative feedback and a nonspecific mechanism of desensitization, and 2) specific kinases that form the growing family of G protein-coupled receptor kinases, which phosphorylate only the activated, or agonist-occupied, forms of GPCRs (13) . Phosphorylation and regulation of GPCRs by second messenger-activated protein kinases are commonly suggested to play a role in heterologous desensitization of GPCRs.
Because both ANG II and TRH activate PKC, it is possible that this kinase might play an important role in heterologous desensitization. Because PKC does not discriminate between agonist-occupied and unoccupied receptors (13) , activation of PKC is believed to be associated with both homologous and heterologous desensitization.
When PKC activation was prevented by 24 h of prior exposure to PMA, homologous and heterologous desensitization induced by ANG II still occurred, suggesting that this process is independent of PKC activation. Similar results for ANG II have been described in cardiomyocytes (38) , bovine adrenal glomerulosa cells (6) , and CHO cells transfected with the AT 1A receptor (9) . It has also been reported that PKC inhibition reduced agonist-induced phosphorylation of the AT 1A receptor but did not affect its desensitization (25) . Nevertheless, the PKC independence has not been a universal finding, because inhibitors of PKC prevented ANG II-mediated desensitization in vascular smooth muscle cells (26) , glomerular mesangial cells (24, 27) , and Xenopus oocytes (30), or they partially reverted ANG II-induced heterologous desensitization in CHO cells (33) . These results confirm that different mechanisms of desensitization occur for the same agonist in different cell types.
Another possible mechanism involved in heterologous desensitization would be downregulation of the Ins(1,4,5)P 3 receptor, which has been shown to participate in heterologous desensitization of responses to ANG II in a rat liver epithelial cell line (5) . Nevertheless, that event was observed only after longer treatments. Results from the present study suggest that the observed reduction in InsP 3 formation per se could explain the decrease in intracellular Ca 2ϩ mobilization.
Desensitization is a complex process that plays an important role in turning off receptor-mediated signal transduction pathways. Although rapid desensitization appears to be a feature common to PLC-linked receptors, the extent and persistence of desensitization have been reported to vary from receptor to receptor. We provide evidence that ANG II induces homologous and heterologous desensitization of [Ca 2ϩ ] i mobilization, InsP 3 formation, and prolactin release in pituitary cells by a mechanism that does not involve PKC activation. Desensitization was rapid in onset and long lasting, although it was not complete because partial responses could be obtained. Time and concentration patterns of desensitization presented similarities and differences with respect to endogenously expressed or transfected AT 1 receptors in different cell types. In light of the development of antihypertensive treatments that use selective AT 1 receptor or angiotensin converting enzyme antagonists, it is important to gain an insight into the physiology of ANG II in the different organs in which it might have an impact.
